Researchers from Stanford Medicine have discovered that cancer cells-to-be accumulate a series of specific genetic changes in a predictable and sequential way years before they are identifiable as pre-malignancies. Many of these changes affect pathways that control cell division, structure, and internal messaging — leaving the cells poised to go bad long before any visible signs or symptoms occur.
The study is the first to exhaustively observe the natural evolution of the earliest stages of human cancers, starting with cells that have a single cancer-priming mutation and culminating with a panel of descendants harboring a galaxy of genetic abnormalities.
Identifying the first steps associated with future cancer development could not only facilitate earlier-than-ever diagnosis — when a deadly outcome is but a twinkle in a rogue cell’s eye — but may also highlight novel interventions that could stop the disease in its tracks, the researchers say.
Curtis is the senior author of the research, which was published on May 31 in Nature. The lead authors of the study are former postdoctoral scholar Kasper Karlsson, Ph.D., and visiting graduate student Moritz Przybilla.
Cells of nefarious beginnings
The research builds on previous work in Curtis’s laboratory indicating that some colon cancer cells are seemingly born to be bad — they acquire the ability to metastasize long before the disease is detectable.
“Our studies of established tumors showed us that early genomic alterations seem to dictate what happens later, and that many of these changes seem to happen before tumor formation,” Curtis said. “We wanted to know what happens at the very earliest stages. How does a cancer cell evolve, and is this evolutionary path repeatable? If we start with a given set of conditions, will we get the same result in every case?”
The researchers studied tiny, three-dimensional clumps of human stomach cells called gastric organoids. The cells were obtained from patients undergoing gastric bypass surgery to treat obesity. At the beginning of the study, the researchers nudged the cells toward cancers by disabling the production of a key cancer-associated protein called p53 that regulates when and how often a cell divides. Mutations in p53 are known to be an early event in many human cancers, and they trigger the accumulation of additional genetic changes including mutations and copy number alterations — in which repetitive regions of the genome are lost or gained during cell division.
Then they waited.
Every two weeks, for two years, Karlsson cataloged the genetic changes occurring in the dividing cells. When Karlsson and Przybilla analyzed the data they found that, although changes occurred randomly, those that conferred greater fitness gave their host cells an evolutionary advantage over other cells in the organoid. As the cells continued to divide and the cycle of mutation and competition repeated over many iterations, the researchers saw some common themes.
Predictable pathways
“There are reproducible patterns,” Curtis said. “Certain regions of the genome are consistently lost very early after the initial inactivation of p53. This was repeatedly seen in cells from independent experiments with the same donor and across donors. This indicates that these changes are cell-intrinsic, that they are hardwired into tumor evolution. At the same time, these cells and organoids appear mostly normal under the microscope. They have not yet progressed to a cancer.”
The researchers found that these early changes usually occur in biological pathways that control when and how often a cell divides, that interfere with a cell’s intricate internal signaling network coordinating the thousands of steps necessary to keep it running smoothly, or that control cell structure and polarity — its ability to know what is “up” and “down” and to situate itself with respect to neighboring cells to form a functioning tissue.
The researchers saw similar patterns occur again and again in cells from different donors. Like water flowing downhill into dry creek beds, the cells traced tried-and-true paths, gaining momentum with each new genetic change. Several of these changes mirror mutations previously observed in stomach cancer and in Barrett’s esophagus, a pre-cancerous condition arising from cells that line the colon and stomach.
“These changes occur in a stereotyped manner that suggests constraints in the system,” Curtis said. “There’s a degree of predictability at the genomic level and even more so at the transcriptomic level — in the biological pathways that are affected — that gives insights into how these cancers arise.”
Curtis and her colleagues plan to repeat the study in different cell types and initiate events other than p53 mutation.
“We’re trying to understand exactly what malignant transformation is,” Curtis said. “What does it mean to catch these cells in the act, about to topple over the edge? We’d like to repeat this study with other tissue types and initiating mutations so we can understand the early genetic events that occur in different organs. And we’d like to study the interplay between the host and the environment. Do inflammatory factors play a role in promoting progression? We know that it matters that the cells in these organoids are communicating with each other, and that is important to understanding progression and treatment response.”
Reference: “Deterministic evolution and stringent selection during preneoplasia” by Kasper Karlsson, Moritz J. Przybilla, Eran Kotler, Aziz Khan, Hang Xu, Kremena Karagyozova, Alexandra Sockell, Wing H. Wong, Katherine Liu, Amanda Mah, Yuan-Hung Lo, Bingxin Lu, Kathleen E. Houlahan, Zhicheng Ma, Carlos J. Suarez, Chris P. Barnes, Calvin J. Kuo and Christina Curtis, 31 May 2023, Nature.
DOI: 10.1038/s41586-023-06102-8
Researchers from Karolinska Institutet, the University College London, and the Chan Zuckerberg Biohub also contributed to the study.
The research was supported by the National Institutes of Health (grants DP1-CA238296 and U01-CA217851) and the Swedish Research Council.

News
The Surprising Origin of a Deadly Hospital Infection
C. diff might not originate from external transmission but rather from within the infected patient themselves. Hospital staff dedicate significant effort to safeguard patients from infections during their hospital stay. Through practices ranging from [...]
Google AI breakthrough – huge step in finding genes that cause diseases
Google says it has made a significant step in identifying disease-causing genes, which could help spot rare genetic disorders. A new model named AlphaMissense is able to confidently classify 89 per cent of all [...]
New Study: Everyday Pleasures Can Boost Cognitive Performance
MINDWATCH study reveals cognitive peaks with everyday pleasures. Listening to music and drinking coffee are the sorts of everyday pleasures that can impact a person’s brain activity in ways that improve cognitive performance, including [...]
Moderna reveals new highly targeted COVID-19 vaccine mRNA-1283
Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine's content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just two [...]
New nanotech weapon takes aim at hard-to-treat breast cancer
Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing treatments. The rapid [...]
Scientists upcycle plastics into liquids that can store hydrogen energy
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have created a process that can upcycle most plastics into chemical ingredients useful for energy storage, using light-emitting diodes (LEDs) and a commercially available catalyst, all [...]
Yale Scientists Uncover How the Immune System Can Alter Our Behavior
The mere scent of seafood can severely sicken those allergic to it — and therefore they are more likely to avoid it. Similarly, individuals who experience food poisoning from a specific dish tend to [...]
Whirlwind Tech – The Future of Energy-Efficient Spintronics Computing
Researchers in Germany and Japan have been able to increase the diffusion of magnetic whirls, so-called skyrmions, by a factor of ten. In today’s world, our lives are unimaginable without computers. Up until now, [...]
Omicron’s Silver Lining: Significantly Lower Risk of Long COVID
Omicron infections have a lower risk of long COVID than earlier variants, according to a study analyzing data from 11,000 participants. The risk of developing long COVID is significantly lower following an infection with [...]
The Hidden Mechanism Connecting Diabetes and Cancer
Researchers have discovered that insulin resistance, typically linked with type 2 diabetes, is also present in cancer patients and can accelerate the spread of the disease. In the 1920s, scientists found that the urine [...]
Scientists Unveil Urea’s Secret Role in the Origin of Life
Scientists from ETH Zurich and the University of Geneva have developed a new technique that allows them to observe chemical reactions taking place in liquids at extremely high temporal resolution. This innovation enables them to track how molecules [...]
Viagra Lowers Alzheimer’s Risk by Almost 70%, Early Study Finds
Research published recently suggests that Pfizer’s erectile dysfunction drug Viagra can decrease the risk of developing Alzheimer’s disease by up to 69 percent. The research, which was published in Nature, found that the medication has [...]
Future of Medical Imaging: Advanced AI Can Tell Your True Age by Looking at Your Chest
An AI-powered model utilizes chest X-rays to help develop biomarkers for aging. What if determining “your age” was based on your chest rather than your face? Scientists from Osaka Metropolitan University have crafted an [...]
Ultra-sensitive biosensors detect cancer in a blood test
Cancer biomarkers circulating in body fluids can be used for diagnosis and treatment monitoring. However, current detection technology lacks the required sensitivity, limiting biomarker use in clinical applications. Colorectal cancer is the second most [...]
Viruses cause 200+ diseases. This one drug may be able to treat them all.
By taking aim at a process common across many viruses, the drug could one day stop any number of known viruses — and new ones. t’s about as audacious an idea as you can [...]
Scientists Identify Potential Treatment for Rare and Devastating Lung Disease
The findings could lead to a cure for LAM. Researchers from the University of Cincinnati may have identified a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung condition resembling cancer found predominantly in women of reproductive [...]